277 results on '"Reese, Jens-Peter"'
Search Results
2. A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation
3. A multicenter, matched case–control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany
4. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
5. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project
6. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort
7. Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort study
8. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany
9. Impact of Clinical Study Implementation on Data Quality Assessments – Using Contradictions within Interdependent Health Data Items as a Pilot Indicator
10. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
11. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study
12. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients
13. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy
14. Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany
15. Versorgung von Parkinson-Patienten in Deutschland
16. Analyse einzelner Qualitätskategorien aus Qualitätsmanagementsystemen und deren Einfluss auf das Gesamtsystem
17. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project
18. Immune correlates against SARS-CoV-2 infection – results of population and hospital-based studies in the IMMUNEBRIDGE project in Germany, 2022
19. General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data
20. Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID
21. Ethical and coordinative challenges setting up a national cohort study during the COVID-19 pandemic in Germany
22. Nurse-led care versus physician-led care in the management of rheumatoid arthritis and psoriatic arthritis (StaerkeR): study protocol for a multi-center randomized controlled trial
23. Das Gesundheitsdatennutzungsgesetz – Potenzial für eine bessere Forschung und Gesundheitsversorgung
24. Estimates of protection against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season - the IMMUNEBRIDGE project
25. Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections
26. Consistency as a Data Quality Measure for German Corona Consensus items mapped from National Pandemic Cohort Network data collections
27. 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP)
28. Culturally adapted cognitive behavioural group therapy for mental disorders in refugees plus problem solving training (ReTreat): study protocol for a multicentre randomised controlled trial
29. Das Gesundheitsdatennutzungsgesetz – Potenzial für eine bessere Forschung und Gesundheitsversorgung
30. Use of antidementia drugs in German patients with Alzheimer’s disease
31. Olfactory dysfunction in Long-COVID
32. Geschmacksstörungen bei long COVID
33. Gustatory dysfunction in long COVID
34. Geruchsstörungen bei Long-COVID
35. The Structured Delegation of Medical Care Services for Patients With Inflammatory Rheumatic Diseases: Findings of a Randomized Controlled Trial (the StärkeR Project)
36. Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020
37. Multicenter, cross-sectional study of the costs of illness and cost-driving factors in adult patients with epilepsy
38. Versorgung von Schlafapnoe-Patienten in Hessen
39. Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020
40. The structured delegation of medical care services for patients with inflammatory rheumatic diseases
41. Multicenter, cross‐sectional study of the costs of illness and cost‐driving factors in adult patients with epilepsy
42. Brief imagery rescripting vs. usual care and treatment advice in refugees with posttraumatic stress disorder: study protocol for a multi-center randomized-controlled trial
43. POTENZIALE DES GESUNDHEITSDATEN- NUTZUNGSGESETZES.
44. Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study
45. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
46. Efficacy of a Low-threshold, Culturally-Sensitive Group Psychoeducation Programme for Asylum Seekers (LoPe): study protocol for a multicentre randomised controlled trial
47. Assessing health-related quality of life in patients with restless legs syndrome
48. Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany—a nationwide population-based study in children and adults
49. Trauma-focused psychodynamic therapy and STAIR Narrative Therapy of post-traumatic stress disorder related to childhood maltreatment: trial protocol of a multicentre randomised controlled trial assessing psychological, neurobiological and health economic outcomes (ENHANCE)
50. Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease: A Methodological Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.